Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Gross Margin: 2023-2025

Historic Gross Margin for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to 100.00%.

  • Camp4 Therapeutics' Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Camp4 Therapeutics' latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Gross Margin registered a high of 100.00% during Q3 2023, and its lowest value of 100.00% during Q3 2023.
  • For the 3-year period, Camp4 Therapeutics' Gross Margin averaged around 100.00%, with its median value being 100.00% (2025).